132 filings
Page 4 of 7
8-K
gtxgs0x16je7s16e91
16 Apr 19
Amendments to Articles of Incorporation or Bylaws
4:27pm
8-K
q8pawtztymzf vnrghhp
11 Apr 19
Entry into a Material Definitive Agreement
4:51pm
8-K
c3tf2
26 Feb 19
Ophthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating Results
7:19am
8-K
ilvcm
7 Jan 19
Results of Operations and Financial Condition
7:59am
8-K
yox7la p4v9
7 Jan 19
Results of Operations and Financial Condition
7:55am
8-K
cvbnd mextsc
14 Dec 18
Departure of Directors or Certain Officers
4:06pm
8-K
byf9qusnu
13 Nov 18
Ophthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular Degeneration
9:20am
8-K
9vzx kovjfntwn
31 Oct 18
Ophthotech Reports Third Quarter 2018 Financial and Operating Results
6:51am
8-K
j4c b6j2c62em0xbn2u
31 Oct 18
Ophthotech Expands Innovative Retinal Disease Pipeline With Acquisition of Versant Ventures’ Inception 4
6:46am
8-K
y5wl v5kla8r
4 Oct 18
Other Events
8:19am
8-K
ac3mh3h05iky6r
22 Aug 18
Other Events
12:00am
8-K
mnb9reg2
1 Aug 18
Ophthotech Reports Second Quarter 2018
7:22am
8-K
vlowqs25g k0ex
5 Jul 18
Entry into a Material Definitive Agreement
4:25pm
8-K
8e9q7
7 Jun 18
Entry into a Material Definitive Agreement
7:07am
8-K
rqpb4v
29 May 18
Departure of Directors or Certain Officers
8:00am
8-K
dylu1r5r8ns1g
14 May 18
Departure of Directors or Certain Officers
7:10am
8-K
j1biobd8z
9 May 18
Ophthotech Reports First Quarter 2018
7:12am
8-K
3h2hkncy8 r34r9f7l
27 Feb 18
Ophthotech Reports Fourth Quarter and Full Year 2017 Financial and Operating Results
12:00am
8-K
57zt4n3euzbj
19 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
38tl0mr7j cnw
10 Jan 18
Results of Operations and Financial Condition
12:00am